학술논문
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
Document Type
Article
Author
Source
In Annals of Oncology May 2016 27(5):843-849
Subject
Language
ISSN
0923-7534